Scholars Central

EditorialPublished 1 Oct 2020

Emerging advances of nanomedicine in cancer therapy.

Authors: Orkideh Martias

Journal of Molecular Oncology Research

Volume 4 · Issue 5 · Pages 14–15

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cancer has become a major cause for deaths around the world, affecting over 10 million new patients every year. At present various treatment methods for cancer includes surgical resection, radiation, and chemotherapy. Although more than 90 chemotherapeutic drugs have been approved by the FDA for therapeutic use, their safety and efficacy has been severely reduced by dose-limiting toxicity and patient morbidity. The common materials used as nanocarriers in nanomedicines for cancer therapy includes polymers, biological nanomaterials, inorganic nanomaterials, liposomes, hydrogels, hybrid nanomaterials and micelles. Compared to conventional therapy, nanotherapeutic drug delivery systems have several potential advantages for cancer therapy, including higher payload capacity, prolonged blood circulation times, reduced toxicity to healthy tissues, and improved anti-tumor efficacy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Oncology Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Oncology Research
  • SubjectOncology & Cancer
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Orkideh Martias”